1. Home
  2. ONC vs GLW Comparison

ONC vs GLW Comparison

Compare ONC & GLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • GLW
  • Stock Information
  • Founded
  • ONC 2010
  • GLW 1851
  • Country
  • ONC Switzerland
  • GLW United States
  • Employees
  • ONC N/A
  • GLW N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • GLW Telecommunications Equipment
  • Sector
  • ONC Health Care
  • GLW Industrials
  • Exchange
  • ONC Nasdaq
  • GLW Nasdaq
  • Market Cap
  • ONC 37.3B
  • GLW 44.4B
  • IPO Year
  • ONC N/A
  • GLW N/A
  • Fundamental
  • Price
  • ONC $330.57
  • GLW $77.73
  • Analyst Decision
  • ONC Strong Buy
  • GLW Strong Buy
  • Analyst Count
  • ONC 9
  • GLW 13
  • Target Price
  • ONC $335.78
  • GLW $66.75
  • AVG Volume (30 Days)
  • ONC 365.5K
  • GLW 8.1M
  • Earning Date
  • ONC 11-11-2025
  • GLW 10-28-2025
  • Dividend Yield
  • ONC N/A
  • GLW 1.45%
  • EPS Growth
  • ONC N/A
  • GLW 83.78
  • EPS
  • ONC N/A
  • GLW 0.94
  • Revenue
  • ONC $4,562,002,000.00
  • GLW $14,206,000,000.00
  • Revenue This Year
  • ONC $875.58
  • GLW $24.39
  • Revenue Next Year
  • ONC $20.99
  • GLW $8.44
  • P/E Ratio
  • ONC N/A
  • GLW $82.08
  • Revenue Growth
  • ONC 47.33
  • GLW 14.63
  • 52 Week Low
  • ONC $170.99
  • GLW $37.31
  • 52 Week High
  • ONC $351.27
  • GLW $77.87
  • Technical
  • Relative Strength Index (RSI)
  • ONC 55.24
  • GLW 86.97
  • Support Level
  • ONC $324.03
  • GLW $66.14
  • Resistance Level
  • ONC $336.80
  • GLW $69.29
  • Average True Range (ATR)
  • ONC 7.92
  • GLW 1.76
  • MACD
  • ONC -0.43
  • GLW 0.63
  • Stochastic Oscillator
  • ONC 64.85
  • GLW 98.81

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About GLW Corning Incorporated

Corning is a leader in materials science, specializing in the production of glass, ceramics, and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.

Share on Social Networks: